Norway· NO-ID_EDA509EB-96C5-415C-B06C-32D37BACB8DA
Enrylaze
A asparaginase product containing recombinant l-asparaginase, registered in Norway by Jazz Pharmaceuticals Ireland Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Asparaginase is registered in 15 of 19 countries.
Countries holding a registration under ATC L01XX02 (asparaginase), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Asparaginase · ATC L01XX02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Recombinant L-Asparaginase
- Manufacturer
- Jazz Pharmaceuticals Ireland Limited
- Country
- Norway (NO)
- ATC code
- L01XX02
- ATC class
- Asparaginase
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_EDA509EB-96C5-415C-B06C-32D37BACB8DA
- no_varenummer5287413 x 0.5NOK 80703.7
- gtin0368727007123
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
280 interactions on record for asparaginase.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Asparaginase · interactions on record
280 records
- 7 severe
- 273 moderate
Most severe, free to view
- ClotrimazoleA01AB18moderate
- Chenodeoxycholic acidA05AA01moderate
- PrednisoloneA07EA01moderate
- HydrocortisoneA07EA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Asparaginase in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEnrylaze 10 mg/0,5 ml Injektions-/infusionsvätska, lösningJazz Pharmaceuticals Ireland Limited
- United KingdomAsparaginase 10,000unit powder for solution for injection vialsImported (Germany)
- BelgiumParonal 10000 IUTakeda Belgium
- JapanＬ－アスパラギナーゼ協和キリン
- CzechiaSPECTRILAMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- PolandSpectrilamedac Gesellschaft fuer klinische Spezialpraeparate mbH
- United StatesRylazeJazz Pharmaceuticals, Inc.
- FinlandSpectrilaMedac Gesellschaft Für Klinische Spezialpräparate mbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Enrylaze, Spectrila
- Liechtenstein · Enrylaze, Spectrila
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5d511df7-f2b1-4903-a7e9-e472ba239672 GET /v1/drugs/5d511df7-f2b1-4903-a7e9-e472ba239672?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjons-/infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Asparaginase",
"merkevare_id": "ID_EDA509EB-96C5-415C-B06C-32D37BACB8DA",
"name_form_strength": "Enrylaze inj/inf, oppl 10 mg/0,5 ml",
"prescription_group": "C"
}See everything about asparaginase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.